UniProt ID | TAF12_HUMAN | |
---|---|---|
UniProt AC | Q16514 | |
Protein Name | Transcription initiation factor TFIID subunit 12 | |
Gene Name | TAF12 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 161 | |
Subcellular Localization | Nucleus . | |
Protein Description | TAFs are components of the transcription factor IID (TFIID) complex, PCAF histone acetylase complex and TBP-free TAFII complex (TFTC). TAFs components-TIIFD are essential for mediating regulation of RNA polymerase transcription.. | |
Protein Sequence | MNQFGPSALINLSNFSSIKPEPASTPPQGSMANSTAVVKIPGTPGAGGRLSPENNQVLTKKKLQDLVREVDPNEQLDEDVEEMLLQIADDFIESVVTAACQLARHRKSSTLEVKDVQLHLERQWNMWIPGFGSEEIRPYKKACTTEAHKQRMALIRKTTKK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 (in isoform 2) | Phosphorylation | - | 31.20 | 22210691 | |
13 | Phosphorylation | PSALINLSNFSSIKP HHHEEECCCCCCCCC | 31.20 | 28122231 | |
16 | Phosphorylation | LINLSNFSSIKPEPA EEECCCCCCCCCCCC | 35.09 | 28122231 | |
17 | Phosphorylation | INLSNFSSIKPEPAS EECCCCCCCCCCCCC | 30.41 | 28122231 | |
19 | Sumoylation | LSNFSSIKPEPASTP CCCCCCCCCCCCCCC | 45.32 | - | |
19 | Sumoylation | LSNFSSIKPEPASTP CCCCCCCCCCCCCCC | 45.32 | 28112733 | |
21 (in isoform 2) | Phosphorylation | - | 48.79 | 22210691 | |
24 | Phosphorylation | SIKPEPASTPPQGSM CCCCCCCCCCCCCCC | 52.76 | 28348404 | |
25 | Phosphorylation | IKPEPASTPPQGSMA CCCCCCCCCCCCCCC | 40.89 | 28348404 | |
30 | Phosphorylation | ASTPPQGSMANSTAV CCCCCCCCCCCCEEE | 14.96 | 28122231 | |
34 | Phosphorylation | PQGSMANSTAVVKIP CCCCCCCCEEEEECC | 14.27 | 26074081 | |
35 | Phosphorylation | QGSMANSTAVVKIPG CCCCCCCEEEEECCC | 24.23 | 26074081 | |
43 | Phosphorylation | AVVKIPGTPGAGGRL EEEECCCCCCCCCCC | 17.13 | 25159151 | |
51 | O-linked_Glycosylation | PGAGGRLSPENNQVL CCCCCCCCCCCCCCC | 28.89 | 30379171 | |
51 | Phosphorylation | PGAGGRLSPENNQVL CCCCCCCCCCCCCCC | 28.89 | 19664994 | |
59 | O-linked_Glycosylation | PENNQVLTKKKLQDL CCCCCCCCHHHHHHH | 41.80 | 30379171 | |
59 | Phosphorylation | PENNQVLTKKKLQDL CCCCCCCCHHHHHHH | 41.80 | 30266825 | |
60 | Ubiquitination | ENNQVLTKKKLQDLV CCCCCCCHHHHHHHH | 43.69 | 27667366 | |
61 | Ubiquitination | NNQVLTKKKLQDLVR CCCCCCHHHHHHHHH | 54.18 | - | |
114 | Ubiquitination | KSSTLEVKDVQLHLE CCCCEEEEEHHHHHH | 42.69 | - | |
140 | Ubiquitination | SEEIRPYKKACTTEA CCCCCCCHHHCCHHH | 36.26 | 27667366 | |
140 | Acetylation | SEEIRPYKKACTTEA CCCCCCCHHHCCHHH | 36.26 | 25953088 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TAF12_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TAF12_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TAF12_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TBP_HUMAN | TBP | physical | 17268553 | |
TAF1A_HUMAN | TAF1A | physical | 17268553 | |
TAF1C_HUMAN | TAF1C | physical | 17268553 | |
CPSF1_HUMAN | CPSF1 | physical | 9311784 | |
ERCC1_HUMAN | ERCC1 | physical | 22323595 | |
TAF4B_HUMAN | TAF4B | physical | 15601843 | |
TBP_HUMAN | TBP | physical | 8663456 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-43 AND SER-51, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51 AND THR-59, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY. |